Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[How to use Japanese guidelines for the treatment of multiple sclerosis].
Diverse functional roles of lipocalin-2 in the central nervous system.
The axes of access--improving care for patients with disabilities.
[Charcot and his legacy to medicine].
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
ACTH gel in the treatment of multiple sclerosis exacerbation: a case study.
The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
Cognitive reserve and patient-reported outcomes in multiple sclerosis.
3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS.
Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis - Yes.
MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
Management of optic neuritis as a clinically first event of multiple sclerosis.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan.
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.
The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
Oligodendroglial markers in the cuprizone model of CNS de- and remyelination.
GeNeuro Announces the Launch of Phase IIb Proof-of-Concept Study with GNbAC1 in Multiple Sclerosis and Servier Equity Investment
The first 10 years with multiple sclerosis: The longitudinal course of daily functioning.
Fine-Tuning S1P Therapeutics.
Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression.
Defining Mild, Moderate, and Severe Pain in Persons with Multiple Sclerosis.

Pages